pubmed· e01.org

PubMed · PMID 23467775

Interleukin-21 overexpression dominates T cell response to Epstein-Barr virus in a fatal case of X-linked lymphoproliferative syndrome type 1.

PMID 23467775Journal Clinical and vaccine immunology : CVIYear 2013Authors 8DOI 10.1128/CVI.00002-13

  • Source PubMed
  • Journal Clinical and vaccine immunology : CVI
  • Year 2013
  • Authors Consuelo Ortega; Orlando A Estévez; Silvia Fernández; Rocío Aguado; José M Rumbao; Teresa Gonzalez; Juan L Pérez-Navero; Manuel Santamaría
  • Licence NLM/PubMed terms

Abstract

Interleukin-21 (IL-21) is a cytokine whose actions are closely related to B cell differentiation into plasma cells as well as to CD8(+) cytolytic T cell effector and memory generation, influencing the T lymphocyte response to different viruses. X-linked lymphoproliferative syndrome type 1 (XLP-1) is a primary immunodeficiency syndrome that is characterized by a high susceptibility to Epstein-Barr virus. We observed in a pediatric patient with XLP-1 that IL-21 was expressed in nearly all peripheral blood CD4(+) and CD8(+) T cells.

However, IL-21 could not be found in the lymph nodes, suggesting massive mobilization of activated cells toward the infection's target organs, where IL-21-producing cells were detected, resulting in large areas of tissue damage.

Record details

PMID23467775
DOI10.1128/CVI.00002-13
JournalClinical and vaccine immunology : CVI
Year2013
AuthorsConsuelo Ortega; Orlando A Estévez; Silvia Fernández; Rocío Aguado; José M Rumbao; Teresa Gonzalez; Juan L Pérez-Navero; Manuel Santamaría
MeSHCD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Epstein-Barr Virus Infections; Fatal Outcome; Herpesvirus 4, Human; Humans; Infant; Interleukins; Lymph Nodes; Lymphocyte Activation; Lymphoproliferative Disorders; Male; T-Lymphocytes, Cytotoxic; Interleukin-21

Source record

Open the PubMed record. This page reproduces the abstract and citation fields held in the local baseline; it does not rehost the article.

Source
PubMed / NLM
PMID
23467775
Rendered
2026-11-20
Completeness
Abstract and citation fields only; full text is not rehosted.